GlassScriptPhysician profile
Lloyd D Hancock
NPI 1083655518
$19,101.99
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $6,550 · 2021: $1,034 · 2022: $551.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $8,680.13 | 2019-2022 | |
| Lilly USA, LLC | $5,446.11 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,031.00 | 2019-2021 | |
| Novo Nordisk INC | $552.30 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $502.30 | 2019-2022 | |
| Corcept Therapeutics | $387.96 | 2019-2022 | |
| Abbvie INC. | $195.75 | 2019-2022 | |
| Insulet Corporation | $175.26 | 2019-2022 | |
| Amarin Pharma, INC. | $119.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $114.42 | 2019-2021 | |
| Abbott Laboratories | $92.13 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $89.19 | 2020-2022 | |
| Lifescan, INC. | $71.32 | 2019-2021 | |
| Ibsa Pharma INC. | $71.20 | 2019-2020 | |
| Shire North American Group INC | $69.00 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.37 | 2019 | |
| Dexcom, INC. | $62.86 | 2021-2022 | |
| Medtronic Minimed, INC. | $58.51 | 2019-2020 | |
| Medtronic, INC. | $51.13 | 2022 | |
| Amgen INC. | $41.72 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $39.72 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $33.35 | 2019 | |
| Companion Medical, INC. | $29.55 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $18.14 | 2021 | |
| Valeritas, INC. | $15.90 | 2019 | |
| Horizon Therapeutics Plc | $15.69 | 2021 | |
| Eisai INC. | $15.59 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.34 | 2022 | |
| Glaxosmithkline, LLC. | $13.76 | 2022 | |
| Vistapharm, INC. | $13.71 | 2021 | |
| Radius Health, INC. | $12.84 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.